1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review

Adv Cancer Res. 1972;16:273-332. doi: 10.1016/s0065-230x(08)60343-7.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Adenocarcinoma / drug therapy
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma / drug therapy
  • Carmustine / administration & dosage
  • Carmustine / therapeutic use*
  • Carmustine / toxicity
  • Cell Line
  • Cell-Free System
  • Chemical Phenomena
  • Chemistry
  • Clinical Trials as Topic
  • Cricetinae
  • Humans
  • Leukemia L1210 / drug therapy
  • Lung Neoplasms / drug therapy
  • Mice
  • Mice, Inbred Strains
  • National Institutes of Health (U.S.)
  • Neoplasm Transplantation
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy
  • Nitrosourea Compounds / administration & dosage
  • Nitrosourea Compounds / therapeutic use*
  • Nitrosourea Compounds / toxicity
  • Rats
  • Sarcoma, Experimental / drug therapy
  • Structure-Activity Relationship
  • United States

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Carmustine